The Effectiveness of Neuropsychological Rehabilitation in Young Dyslexic Adults
NCT ID: NCT01930500
Last Updated: 2019-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2012-11-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapy for Reading Problems in Adults After Brain Injury
NCT00064805
Efficacy Study of a Neuropsychological Rehabilitation Intervention for Children With Non-symptomatic Epilepsy
NCT04292093
Cognitive Impairment in Pediatric Onset Multiple Sclerosis
NCT03190902
Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation Program
NCT02193906
The Effects of Attention Retraining in MS
NCT01492023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To study whether neuropsychological rehabilitation improves the psychosocial wellbeing and perceived cognitive deficits in dyslexic young adults and to evaluate potential differences between individual and group based neuropsychological rehabilitation.
Methods: Altogether 120 young adults diagnosed with dyslexia are randomized either to one of the intervention groups (individual neuropsychological rehabilitation / group neuropsychological rehabilitation) or to a control group which will receive either one of the interventions after a 5 month waiting period. All the study subjects are assessed with a short neuropsychological test battery as well as self-rating questionnaires evaluating mood, QoL, perceived cognitive deficits, and the impact of the learning disability at baseline, after five months (immediately after interventions or control period) and after 10 months. After 20 months a shorter follow-up using only self-ratings will be done via mail. Subjects in the intervention groups are offered neuropsychological rehabilitation in 12 sessions conducted once a week or once in two weeks during five months. Subjects in the control group do not receive any intervention for the first five months.
Results: The effects of interventions on psychosocial wellbeing and perceived cognitive deficits are evaluated using appropriate statistical procedures and comparing the differences between the interventions groups and the control group.
The present status: All the interventions are completed, follow-up data is still beeing collected
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individual neuropsychological rehabilitation
12 times 90 minutes, once per week or once per two weeks, during 5 months
Individual neuropsychological rehabilitation
Psychoeducation, teaching compensatory strategies and offering psychological support to better cope with dyslexia
Group based neuropsychological rehabilitation
12 times 120 minutes + a brake, once per week or once per two weeks, during 5 months
Group based neuropsychological rehabilitation
Psychoeducation, teaching compensatory strategies and offering psychological support and peer support to better cope with dyslexia
Control group
Control group does not receive neuropsychological rehabilitation or any other intervention during the first 5 months. After the control period they will be randomized to receive either individual or group based rehabilitation.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Individual neuropsychological rehabilitation
Psychoeducation, teaching compensatory strategies and offering psychological support to better cope with dyslexia
Group based neuropsychological rehabilitation
Psychoeducation, teaching compensatory strategies and offering psychological support and peer support to better cope with dyslexia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18-35
* problems in studies, work or employment relating to dyslexia
* subjective and objective need for rehabilitation
* the native language is Finnish
Exclusion Criteria
* other learning disabilities than dyslexia
* overall weak cognitive capacity
* psychiatric diagnosis
* severe depression
* alcohol or drug abuse
* neuropsychological rehabilitation received at the age of 16 or later
18 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Social Insurance Institution, Finland
OTHER
Rehabilitation Foundation, Finland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erja Poutiainen, PhD
Role: STUDY_DIRECTOR
Rehabilitation Foundation
Johanna Nukari, LicPsych
Role: PRINCIPAL_INVESTIGATOR
Rehabilitation Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehabilitation Foundation
Helsinki, Malminkartano, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Luki-40211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.